Gene transfer vectors based on adeno-associated virus (AAV) have shown great promise for human gene therapy. AAV has attractive gene transfer properties. Wild-type AAV consists of a single-stranded DNA genome encoding replication (rep) and encapsidation (cap) genes flanked by inverted terminal repeats (ITRs). Recombinant AAV vectors are typically produced by transient transfection using a "gutless" vector approach. The therapeutic gene of interest is inserted along with regulatory elements between the 5' and 3' viral inverted terminal repeats (ITRs) and encoded on one plasmid. The rep and cap functions are provided in trans on separate plasmids, and a third plasmid provides the required adenoviral helper genes E4, E2, and Va RNA.
Due to the ability of AAV9 vectors to penetrate the blood-brain barrier, they can be used to transfer genes en bloc to the brain and spinal cord, which has led to the treatment of a variety of central nervous system diseases via intravascular gene delivery. Intravenous administration of scAAV9 vectors has been shown to be a feasible and translatable approach for targeting the CNS in mice, cats, and non-human primates, and the approach is being used in human trials for spinal muscular atrophy. These studies have demonstrated the ability of AAV9 to achieve broad CNS transduction, all of which rely on more efficient self-complementary AAV (scAAV) vector designs. In vivo testing has shown that scAAV vectors are more than 10-fold more efficient at transducing cells compared to conventional single-stranded AAV (ssAAV) vectors.
Birdsong, like human language, consists of a sequence of temporally precise movements acquired through vocal learning. The learning of such sequential vocalizations depends on the neural function of the motor cortex and basal ganglia. Here, researchers used the songbird zebra finch as an animal model to explore the function of connections between the cortex-like (HVC) and basal ganglia (area X), which are connected via HVC(X) projection neurons and have temporally precise firing during singing. By specifically ablating HVC(X) neurons, juvenile zebra finches failed to imitate the acoustics of the guide syllables and developed songs that were temporally unstable with poor sequence consistency. In contrast, HVC(X)-ablated adults did not alter their learned song structure, but generated acoustic fluctuations and responded to auditory feedback disruption by the introduction of song deterioration, as did normal adults. These results suggest that cortico-basal ganglia inputs are important for learning the acoustic and temporal aspects of song structure but not for generating vocal fluctuations that help maintain already learned vocal patterns.
The researchers first injected scAAV9-Cre and scAAV9-FLExmRuby2 into area X and HVC, respectively, to test the induction rate and expression time of the target gene (i.e., mRuby2) in HVC(X) neurons. One week after injection, selective expression of mRuby2 protein in HVC(X) neurons was observed (Figure 1C). Neurotensin (NTS) mRNA was used as a marker of HVC(X) neurons. The study confirmed that NTS mRNA was specifically expressed in HVC(X) neurons labeled by retrograde cholera toxin B (CTB) injected into area X, but not in HVC(RA) neurons (Figure 1D). Using NTS labeling, a reliable estimation of residual HVC(X) neuron number after ablation could be performed without additional retrograde labeling from area X to HVC. The researchers then injected scAAV9-Cre into area X of the test hemisphere and injected a mixture of scAAV9-FLEx-dtA and -caCasp into HVC. In the other hemisphere of the same animal, scAAV9-Cre and scAAV9-FLEx-mRuby2 were injected into area X and HVC, respectively, to serve as the control hemisphere. The number of HVC(X) neurons was compared between the control and HVC(X)-ablated hemispheres (Figure 1D). As a result, the residual number of HVC(X) neurons was reduced to 23.9 to 57.2% in the ablated hemisphere when compared to the control HVC of the same individual. Although the cell ablation procedure failed to completely remove HVC(X) neurons, the approach using the mixture of dtA and caCasp showed a similar or higher rate of effective reduction of target cells compared to previous efforts to perform cell ablation in songbirds.
Figure 1. Specific ablation of HVC(X) neurons projecting to the basal ganglia area X. (Sánchez-Valpuesta M, et al., 2019)
Customer Reviews
Reliable Results
We’ve used scAAV9-Cre in multiple experiments, and it consistently delivers reliable results. The transduction efficiency is impressive, and we have achieved consistent gene recombination across different batches.
Write a Review